LivaNova PLC
LIVN
株式のランク
#3853
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
株価
$78.59
時価総額
$4.32B
変化（1日）
-1.40%
変化（1年）
43.65%
国
GB
取引 LivaNova PLC (LIVN)
カテゴリー
Healthcare
LivaNova PLC（LIVN）の発行済株式数
June 2026 時点の発行済株式数 55.00M
LivaNova PLC の最新の財務報告および株価によると、現在の発行済株式数は 55.00M です。December 2023 の終わりには、同社は 53.90M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
LivaNova PLC（LIVN）の発行済株式数の履歴（2000 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 55.00M | 1.40% |
| 2024 | 54.24M | 0.63% |
| 2023 | 53.90M | 0.75% |
| 2022 | 53.50M | 5.66% |
| 2021 | 50.63M | 4.20% |
| 2020 | 48.59M | 0.50% |
| 2019 | 48.35M | -0.30% |
| 2018 | 48.50M | 0.61% |
| 2017 | 48.20M | -1.35% |
| 2016 | 48.86M | 85.14% |
| 2015 | 26.39M | -2.77% |
| 2014 | 27.14M | -1.67% |
| 2013 | 27.60M | -0.80% |
| 2012 | 27.83M | -0.80% |
| 2011 | 28.05M | 1.26% |
| 2010 | 27.70M | 4.02% |
| 2009 | 26.63M | 0.50% |
| 2008 | 26.50M | 3.86% |
| 2007 | 25.51M | 2.40% |
| 2006 | 24.92M | 3.66% |
| 2005 | 24.04M | 4.10% |
| 2004 | 23.09M | 4.79% |
| 2003 | 22.03M | 1.75% |
| 2002 | 21.66M | 20.01% |
| 2000 | 18.04M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 1.74B | 3,069.18% |
US
|
|
| 1.28B | 2,231.09% |
IE
|
|
| 383.50M | 597.27% |
US
|
|
| 1.48B | 2,586.55% |
US
|
|
| - | - |
DE
|
